tiprankstipranks
Advertisement
Advertisement

TSHA Stock Latest News

ASPIRE Rett Syndrome Trial Puts Taysha’s TSHA-102 Gene Therapy in Focus for Investors
Company AnnouncementsASPIRE Rett Syndrome Trial Puts Taysha’s TSHA-102 Gene Therapy in Focus for Investors
3d ago
TSHA
FDA Commissioner Marty Makary resigns
PremiumThe Fly
FDA Commissioner Marty Makary resigns
13d ago
AZN
BMY
Taysha Gene Therapies Ramps Up Ahead of TSHA-102 BLA
PremiumCompany Announcements
Taysha Gene Therapies Ramps Up Ahead of TSHA-102 BLA
15d ago
TSHA
Whitney Ijem Reiterates Buy Rating and Maintains $17 Price Target on Clinical Momentum and Strong Cash Runway
PremiumRatings
Whitney Ijem Reiterates Buy Rating and Maintains $17 Price Target on Clinical Momentum and Strong Cash Runway
18d ago
TSHA
Taysha Gene Therapies reports Q1 EPS (12c), consensus (10c)
PremiumThe Fly
Taysha Gene Therapies reports Q1 EPS (12c), consensus (10c)
19d ago
TSHA
Unusually active option classes on open April 16th
PremiumThe FlyUnusually active option classes on open April 16th
1M ago
PEP
BULL
Buy Rating on Taysha Gene Therapies Driven by Strong Leadership, Strategic Positioning, and Attractive Risk‑Reward Upside
Premium
Ratings
Buy Rating on Taysha Gene Therapies Driven by Strong Leadership, Strategic Positioning, and Attractive Risk‑Reward Upside
1M ago
TSHA
Advancing Gene Therapy Programs and Strengthened Valuation Support Taysha Buy Rating and $17 Target
Premium
Ratings
Advancing Gene Therapy Programs and Strengthened Valuation Support Taysha Buy Rating and $17 Target
2M ago
TSHA
Taysha Gene Therapies price target raised to $17 from $14 at Canaccord
PremiumThe Fly
Taysha Gene Therapies price target raised to $17 from $14 at Canaccord
2M ago
TSHA
Taysha Gene Therapies Signals Momentum in Earnings Call
PremiumCompany Announcements
Taysha Gene Therapies Signals Momentum in Earnings Call
2M ago
TSHA
Taysha Gene Therapies reports 2025 EPS (34c), consensus (34c)
PremiumThe Fly
Taysha Gene Therapies reports 2025 EPS (34c), consensus (34c)
2M ago
TSHA
Taysha Gene Therapies management to meet with Cantor
PremiumThe Fly
Taysha Gene Therapies management to meet with Cantor
2M ago
TSHA
Taysha Gene Therapies announces inducement grant under Nasdaq listing rule
PremiumThe FlyTaysha Gene Therapies announces inducement grant under Nasdaq listing rule
3M ago
TSHA
TSHA Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
TSHA Earnings this Week: How Will it Perform?
3M ago
TSHA
Taysha Gene Therapies announces inducement grant under Nasdaq listing rule
Premium
The Fly
Taysha Gene Therapies announces inducement grant under Nasdaq listing rule
4M ago
TSHA
Aehr, Fastenal, Regions, Abeona, Taysha: Insider Firestorm
PremiumWeekend Updates
Aehr, Fastenal, Regions, Abeona, Taysha: Insider Firestorm
4M ago
RF
ABEO
Regulatory Clarity and Broad Rett Syndrome Opportunity Drive Taysha Gene Therapies Buy Rating and $10 Target
PremiumRatings
Regulatory Clarity and Broad Rett Syndrome Opportunity Drive Taysha Gene Therapies Buy Rating and $10 Target
5M ago
TSHA
Taysha Gene Therapies announces progress across TSHA-102
PremiumThe Fly
Taysha Gene Therapies announces progress across TSHA-102
5M ago
TSHA
Taysha Gene Therapies price target raised to $11 from $8 at Wells Fargo
PremiumThe Fly
Taysha Gene Therapies price target raised to $11 from $8 at Wells Fargo
5M ago
TSHA
Taysha Gene Therapies rated Buy versus Early-Stage at Goldman Sachs
PremiumThe FlyTaysha Gene Therapies rated Buy versus Early-Stage at Goldman Sachs
6M ago
TSHA
Taysha price target raised to $19 from $13 at Cantor Fitzgerald
Premium
The Fly
Taysha price target raised to $19 from $13 at Cantor Fitzgerald
6M ago
TSHA
Citizens JMP healthcare analysts hold an analyst/industry conference
Premium
The Fly
Citizens JMP healthcare analysts hold an analyst/industry conference
6M ago
BNTC
CRSP

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >